Clinical Trial Update: COMMODITIES Trial: Initial Dual Oral Therapy vs Monotherapy in PAH With Cardiovascular Comorbidities [Phase 3]

View source ↗

Summary

Phase 3 clinical trial entry comparing initial dual oral therapy versus monotherapy for pulmonary arterial hypertension with cardiovascular comorbidities; the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Pulmonary Arterial Hypertension

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Pulmonary Arterial Hypertension (PAH), Comorbidities | Phase 3 | Status: NOT_YET_RECRUITING